Analysis of Alprostadil by HPLC with Post-Column Derivatization

Published on: 

Special Issues

LCGC Supplements, Special Issues-12-01-2014, Volume 32, Issue 12

Alprostadil (Prostaglandin E1) is a drug that has vasodilation properties and is used to treat erectile dysfunction and other medical conditions. This medication is available in injectable form and in suppository form. Since Prostaglandin E1 has low UV absorbance, the analysis of the formulations could be difficult. The addition of post-column derivatization increases the sensitivity and specificity of the analysis.

Analytical Conditions

Analytical column: Reversed-phase C18 column (150 × 4.6 mm)
Temperature: 37 °C
Flow rate: 1 mL/min
Mobile phase: 30% Acetonitrile - 70% of 0.02 M Potassium Phosphate monobasic (adjusted to pH 3)

Or Alternative Conditions


Mobile phase: 25% Acetonitrile – 75% of 0.0067 M Potassium Phosphate buffer pH 6.3
Injection volume: 20 µL

Post-Column Conditions

Post-column system: Pinnacle PCX
Reactor volume: 2 mL
Reactor temperature: 60 °C
Reagent: 1 mol/L Potassium Hydroxide
Reagent flow rate: 1 mL/min
Detection: UV 278 nm


Alprostadil: 0.1–10 µg/mL
β-Naphthol (internal standard) 0.25–10 µg/mL

Make stock solutions of Alprostadil and β-Naphthol in anhydrous Ethanol. Prepare working standards by appropriate dilution of stock solution with mobile phase.

Pickering Laboratories, Inc.
1280 Space Park Way, Mountain View, CA 94043
tel. (800) 654-3330, (650) 694-6700